Research and Markets: Several Promising Neuroprotective Drug Compounds for Treatment of Stroke in Development.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c12812) has announced the addition of Neuroprotection in Stroke - Protecting the Brain Sells to their offering Stroke is one of the leading causes of death and adult disability worldwide. Nevertheless, acute treatments for stroke are severely limited. Neuroprotective drugs, which boast the ability to halt the ischemic cascade ischemic cascade Vascular disease A series of events lasting for hrs to several days after an initial ischemic event that results in extensive necrosis and tissue damage beyond the tissue zone first affected by the initial lack of blood flow , offer huge hope to sufferers, but as yet, no such compound has received US approval. Successful neuroprotection is limited by the short window of opportunity for active intervention A procedure used in a lawsuit by which the court allows a third person who was not originally a party to the suit to become a party, by joining with either the plaintiff or the defendant. . A more in-depth understanding of the mechanisms involved in cell injury and death is needed to aid drug development. The cascade of cell death is multi-faceted and although simple single target mechanisms have shown some efficacy in pre-clinical trials, a more complex multi targeted approach may prove more successful in patients. Several promising compounds are currently in development. This report provides: Overview of the potential size of the ischemic stroke Noun 1. ischemic stroke - the most common kind of stroke; caused by an interruption in the flow of blood to the brain (as from a clot blocking a blood vessel) ischaemic stroke patient population Examination of current clinical practice including diagnosis and both preventative and acute treatment for stroke Evaluation of the opportunity for neuroprotective compounds in the potential treatment of stroke Review of key products currently in development This information will enable readers: Gain a top-line overview of the patient potential and current treatment in the stroke market Understand the unmet un·met adj. Not satisfied or fulfilled: unmet demands. need of neuroprotection in stroke Evaluate future players in this market For more information visit http://www.researchandmarkets.com/reports/c12812 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion